These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 2813409)

  • 1. Inhibition of allorecognition by an H-2Kb-derived peptide is evidence for a T-cell binding region on a major histocompatibility complex molecule.
    Schneck J; Munitz T; Coligan JE; Maloy WL; Margulies DH; Singer A
    Proc Natl Acad Sci U S A; 1989 Nov; 86(21):8516-20. PubMed ID: 2813409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis of Kbm8 alloreactivity. Amino acid substitutions on the beta-pleated floor of the antigen recognition site.
    Hunt HD; Pullen JK; Dick RF; Bluestone JA; Pease LR
    J Immunol; 1990 Sep; 145(5):1456-62. PubMed ID: 2384667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A soluble divalent class I major histocompatibility complex molecule inhibits alloreactive T cells at nanomolar concentrations.
    Dal Porto J; Johansen TE; Catipović B; Parfiit DJ; Tuveson D; Gether U; Kozlowski S; Fearon DT; Schneck JP
    Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6671-5. PubMed ID: 8341685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of an allospecific T cell hybridoma by soluble class I proteins and peptides: estimation of the affinity of a T cell receptor for MHC.
    Schneck J; Maloy WL; Coligan JE; Margulies DH
    Cell; 1989 Jan; 56(1):47-55. PubMed ID: 2783386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD8 expression alters the fine specificity of an alloreactive MHC class I-specific T hybridoma.
    Blok R; Margulies DH; Pease L; Ribaudo RK; Schneck J; McCluskey J
    Int Immunol; 1992 Apr; 4(4):455-66. PubMed ID: 1591216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An immunodominant epitope present in multiple class I MHC molecules and recognized by cytotoxic T lymphocytes.
    Mann DW; McLaughlin-Taylor E; Wallace RB; Forman J
    J Exp Med; 1988 Jul; 168(1):307-24. PubMed ID: 2456370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presentation of a horse cytochrome c peptide by multiple H-2b class I major histocompatibility complex (MHC) molecules to C57BL/6- and bm1-derived cytotoxic T lymphocytes: presence of a single MHC anchor residue may confer efficient peptide-specific CTL recognition.
    Sheil JM; Schell TD; Shepherd SE; Klimo GF; Kioschos JM; Paterson Y
    Eur J Immunol; 1994 Sep; 24(9):2141-9. PubMed ID: 7522163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A viral peptide can mimic an endogenous peptide for allorecognition of a major histocompatibility complex class I product.
    Guimezanes A; Schumacher TN; Ploegh HL; Schmitt-Verhulst AM
    Eur J Immunol; 1992 Jun; 22(6):1651-4. PubMed ID: 1318201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alloantigenic sites on class I major histocompatibility complex antigens: 61-69 region in the first domain of the H-2Kb molecule induces specific antibody and T cell responses.
    Singh B; Waters CA; Swanlund D
    J Immunol; 1986 Oct; 137(7):2311-8. PubMed ID: 2428867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of coreceptor versus accessory molecule function of CD8 as a correlate of exogenous peptide concentration.
    Knall C; Ingold A; Potter TA
    Mol Immunol; 1994 Aug; 31(12):875-83. PubMed ID: 8065371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide-dependent recognition of H-2Kb by alloreactive cytotoxic T lymphocytes.
    Heath WR; Hurd ME; Carbone FR; Sherman LA
    Nature; 1989 Oct; 341(6244):749-52. PubMed ID: 2477713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allospecific cytolytic T lymphocytes recognize conformational determinants on hybrid mouse transplantation antigens.
    Bluestone JA; Foo M; Allen H; Segal D; Flavell RA
    J Exp Med; 1985 Jul; 162(1):268-81. PubMed ID: 2409207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonal analysis of H-2Kb + TNP recognition by T cells with the use of H-2Kbm mutants and H-2Kb-specific monoclonal antibodies.
    Davignon JL; Guimezanes A; Schmitt-Verhulst AM
    J Immunol; 1983 Sep; 131(3):1073-9. PubMed ID: 6193173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular basis for the recognition of two structurally different major histocompatibility complex/peptide complexes by a single T-cell receptor.
    Brock R; Wiesmüller KH; Jung G; Walden P
    Proc Natl Acad Sci U S A; 1996 Nov; 93(23):13108-13. PubMed ID: 8917552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of mutations in the MHC class I peptide binding groove on the cytotoxic T lymphocyte recognition of the Kb-restricted ovalbumin determinant.
    Nikolić-Zugić J; Carbone FR
    Eur J Immunol; 1990 Nov; 20(11):2431-7. PubMed ID: 2253683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Threshold tolerance in H-2Kb-specific TCR transgenic mice expressing mutant H-2Kb: conversion of helper-independent to helper-dependent CTL.
    Auphan N; Jézo-Brémond A; Schönrich G; Hämmerling G; Arnold B; Malissen B; Schmitt-Verhulst AM
    Int Immunol; 1992 Dec; 4(12):1419-28. PubMed ID: 1286065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-MHC-restricted peptides recognized by an alloreactive T lymphocyte clone.
    Udaka K; Wiesmüller KH; Kienle S; Jung G; Walden P
    J Immunol; 1996 Jul; 157(2):670-8. PubMed ID: 8752916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide loading of empty major histocompatibility complex molecules on RMA-S cells allows the induction of primary cytotoxic T lymphocyte responses.
    De Bruijn ML; Schumacher TN; Nieland JD; Ploegh HL; Kast WM; Melief CJ
    Eur J Immunol; 1991 Dec; 21(12):2963-70. PubMed ID: 1660811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping of epitopes recognized by alloreactive cytotoxic T lymphocytes using inhibition by MHC peptides.
    Heath WR; Vitiello A; Sherman LA
    J Immunol; 1989 Sep; 143(5):1441-6. PubMed ID: 2474598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different types of allospecific CTL clones identified by their ability to recognize peptide loading-defective target cells.
    Aosai F; Ohlen C; Ljunggren HG; Höglund P; Franksson L; Ploegh H; Townsend A; Kärre K; Stauss HJ
    Eur J Immunol; 1991 Nov; 21(11):2767-74. PubMed ID: 1936122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.